{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:39:22Z","timestamp":1759412362488,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Public Foundation of the Vaccination Research Center and the Japan Agency for Medical Research and Development","award":["19fk0108066h1702"],"award-info":[{"award-number":["19fk0108066h1702"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.vaccine.2020.09.038","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T05:28:10Z","timestamp":1601443690000},"page":"7331-7336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Trend in varicella patients 4\u00a0years after implementation of universal two-dose varicella vaccination in Japan"],"prefix":"10.1016","volume":"38","author":[{"given":"Fumihiko","family":"Hattori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Higashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Ihira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsushi","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.09.038_b0005","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.09.038_b0010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s10156-013-0577-x","article-title":"Varicella vaccination in Japan: necessity of implementing a routine vaccination program","volume":"19","author":"Ozaki","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2020.09.038_b0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpeds.2003.10.025","article-title":"Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era","volume":"144","author":"Patel","year":"2004","journal-title":"J Pediatr"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2020.09.038_b0020","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites\u2013United States, 1995\u20132005","volume":"197","author":"Guris","year":"2008","journal-title":"J infect Dis"},{"key":"10.1016\/j.vaccine.2020.09.038_b0025","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1542\/peds.2004-0012","article-title":"Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States","volume":"114","author":"Davis","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2020.09.038_b0030","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.09.038_b0035","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States, 1995\u20132000","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2020.09.038_b0040","unstructured":"National Institute of Infectious Diseases, Japan. Varicella (chickenpox) cases reported per sentinel weekly, https:\/\/www.niid.go.jp\/niid\/ja\/10\/2096-weeklygraph\/1648-05varicella.html."},{"key":"10.1016\/j.vaccine.2020.09.038_b0045","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1016\/j.vaccine.2017.07.090","article-title":"Evaluating the effectiveness of the universal immunization program against varicella in Japanese children","volume":"35","author":"Hattori","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.09.038_b0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcv.2019.07.009","article-title":"Reliability of direct varicella zoster virus loop-mediated isothermal amplification method for rapid diagnosis of breakthrough varicella","volume":"119","author":"Higashimoto","year":"2019","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2020.09.038_b0055","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1128\/JCM.00216-08","article-title":"Discriminating between varicella-zoster virus vaccine and wild-type strains by loop-mediated isothermal amplification","volume":"46","author":"Higashimoto","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.09.038_b0060","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1086\/515638","article-title":"Recombinant varicella-zoster virus glycoproteins E and I: immunologic responses and clearance of virus in a guinea pig model of chronic uveitis","volume":"178","author":"Kimura","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.09.038_b0065","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/INF.0000000000000444","article-title":"Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students","volume":"33","author":"Thomas","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.09.038_b0070","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/INF.0000000000001475","article-title":"Laboratory diagnosis of breakthrough varicella in children","volume":"36","author":"Watanabe","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.09.038_b0075","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/INF.0b013e31819c1041","article-title":"An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients\u2013Arkansas, 2006","volume":"28","author":"Gould","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.09.038_b0080","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1016\/j.vaccine.2018.08.048","article-title":"Descriptive epidemiology of varicella based on national surveillance data before and after the introduction of routine varicella vaccination with two doses in Japan, 2000\u20132017","volume":"36","author":"Morino","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.09.038_b0085","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.1016\/j.vaccine.2012.07.076","article-title":"Challenges in confirming a varicella outbreak in the two-dose vaccine era","volume":"30","author":"Mahamud","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.09.038_b0090","doi-asserted-by":"crossref","unstructured":"Grose C. Varicella vaccination of children in the United States: assessment after the first decade 1995-2005. J Clin Virol 2005; 33: 89\u201395; discussion 6-8.","DOI":"10.1016\/j.jcv.2005.02.003"},{"key":"10.1016\/j.vaccine.2020.09.038_b0095","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2020.09.038_b0100","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/522150","article-title":"Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997\u20132005","volume":"197","author":"Chaves","year":"2008","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2020.09.038_b0105","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1086\/522148","article-title":"Laboratory diagnosis and characteristics of breakthrough varicella in children","volume":"197","author":"Weinmann","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.09.038_b0110","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1542\/peds.92.6.833","article-title":"Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka\/Merck varicella vaccine","volume":"92","author":"Bernstein","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2020.09.038_b0115","unstructured":"Ministry of Health, Labour and Welfare, Japan. National surveillance of demographic survey in Japan, https:\/\/www.e-stat.go.jp\/en\/dbview?sid=0003216242."},{"key":"10.1016\/j.vaccine.2020.09.038_b0120","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1016\/j.vaccine.2017.06.065","article-title":"Varicella outbreak in a highly-vaccinated school population in Beijing, China during the voluntary two-dose era","volume":"35","author":"Suo","year":"2017","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.09.038_b0125","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.vaccine.2009.10.086","article-title":"Comparative varicella vaccine effectiveness during outbreaks in day-care centres","volume":"28","author":"Spackova","year":"2010","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.09.038_b0130","doi-asserted-by":"crossref","first-page":"972","DOI":"10.2105\/AJPH.2014.302229","article-title":"An evaluation of voluntary 2-dose varicella vaccination coverage in New York City public schools","volume":"105","author":"Doll","year":"2015","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2020.09.038_b0135","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/INF.0b013e31820eae6a","article-title":"Second-dose varicella vaccination coverage in children and adolescents in a managed care organization in California, 2006\u20132009","volume":"30","author":"Hechter","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.09.038_b0140","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1186\/s12889-017-4725-6","article-title":"Heterogeneity in coverage for measles and varicella vaccination in toddlers - analysis of factors influencing parental acceptance","volume":"17","author":"Hagemann","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2020.09.038_b0145","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/INF.0b013e3182567d1a","article-title":"Correlates for second-dose varicella vaccination in school-age children in a managed care organization in California","volume":"31","author":"Hechter","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.09.038_b0150","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/INF.0b013e31827f4c3c","article-title":"Factors associated with receipt of two doses of varicella vaccine among adolescents in the United States","volume":"32","author":"Kawai","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2020.09.038_b0155","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1086\/522139","article-title":"Status of school entry requirements for varicella vaccination and vaccination coverage 11 years after implementation of the varicella vaccination program","volume":"197","author":"Lopez","year":"2008","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20311981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20311981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:48:55Z","timestamp":1759402135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20311981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":31,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0264410X20311981"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.09.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trend in varicella patients 4\u00a0years after implementation of universal two-dose varicella vaccination in Japan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}